Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 2/2014

01-02-2014 | Erratum

Erratum to: PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer

Authors: J. Li, Z. Yang, Q. Zou, Y. Yuan, J. Li, L. Liang, G. Zeng, S. Chen

Published in: Clinical and Translational Oncology | Issue 2/2014

Login to get access

Excerpt

In the published original article, some details in the affiliation of the first author J. Li are missing. The correct affiliation is given below. …
Metadata
Title
Erratum to: PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer
Authors
J. Li
Z. Yang
Q. Zou
Y. Yuan
J. Li
L. Liang
G. Zeng
S. Chen
Publication date
01-02-2014
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 2/2014
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-013-1123-0

Other articles of this Issue 2/2014

Clinical and Translational Oncology 2/2014 Go to the issue

Research Article

Selecting housekeeping genes as references for the normalization of quantitative PCR data in breast cancer

Research Article

MCAM expression is associated with poor prognosis in non-small cell lung cancer

Special Article

Cytoreductive surgery and intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis from colorectal origin

Research Article

PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer

Research Article

What is the future burden of HPV-related cancers in Spain?

Research Article

Analysis of serum proteome profiles in nasopharyngeal carcinoma with different radiosensitivity
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits